Á lódáil...
TOP: Time-to-Event Bayesian Optimal Phase II Trial Design for Cancer Immunotherapy
BACKGROUND: Immunotherapies have revolutionized cancer treatment. Unlike chemotherapies, immune agents often take longer to show benefit, and the complex and unique mechanism of action of these agents renders the use of multiple endpoints more appropriate in some trials. These new features of immuno...
Na minha lista:
| Foilsithe in: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Oxford University Press
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204709/ https://ncbi.nlm.nih.gov/pubmed/30924863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djz049 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|